The use of modeling and simulation as a predictive tool for research in biology is becoming increasingly popular. However, outputs from such simulations are often abstract and presented in a very different manner to equivalent data from the biological domain. Therefore, we have developed a flexible tool-chain for emulating various biological laboratory techniques to produce biologically homomorphic outputs in computer simulations. This includes virtual immunohistochemistry, microscopy, flow cytometry, and gene expression heatmaps. We present a case study in the use of this tool-chain applied to a simulation of pre-natal lymphoid organ development. We find that application of the tool-chain provides additional, biologically relevant data, that is inaccessible with pre-existing methodologies for analysis of simulation results. We argue that biological experimental techniques borrowed from the wet-lab are an important additional approach to the analysis of simulations in computational biology, and might furthermore inspire confidence in simulation results from the perspective of experimental biologists.
Introduction & Background
In silico simulations of biological processes, including disease pathology, tissue development, immune responses, and evolutionary processes, have a demonstrated ability to offer new insight into complex biological systems that are difficult to study solely in wet laboratories. Computational models offer qualitative and quantitative insights into complex systems, in which biological behaviors emerge from the interactions of many individual entities. For instance, by capturing the dynamics of cells signalling each other through both direct contact and through the secretion and detection of molecules in their local environment. We have previously demonstrated that agent-based spatially resolved simulations, when properly validated, have the capacity to explore disease intervention strategies such as the administration of drugs or biological therapeutics, or the simulation of surgery by removing or modifying individual model compartments . Agent-based simulations of biology are often much more complex than mathematical models based on differential equations, as they capture emergent phenomena in terms of spatially-resolved individuals rather than at the population level. Such simulations often require a very large parameter space and fine spatial resolution. Therefore, it is extremely important that such simulations can be properly validated and calibrated in order for us to have confidence in their results and predictions.
Calibration is typically achieved in the first instance 'by hand', that is, the parameter space is explored in conjunction with a domain expert, until the simulation outputs correspond to those measured experimentally. Simulations are often calibrated against one experiment, which is unlikely to be adequate if the simulation is then used to explore the properties of the system in other contexts. For this reason, Read et al. (2013) argues for use of multiple calibration points when developing simulations. However, due to the limitations of observation in the biological domain, simulation outputs usually take on a very different form to in vivo or in vitro experiments that model the same process. Many simulations have parameters that are not directly measurable with current technology, which must be inferred from statistical analysis of the simulation results and calibration against primary data from biological experiments. The difficulty of this task may be compounded by the different nature of simulation output to primary data. Sensitivity analysis should be performed over the parameter space for every biological simulation, using techniques that measure the effect magnitude of each simulation parameter individually, such as the Vargha-Delaney A-Test (Vargha and Delaney, 2000) , and Latin Hypercube parameter sampling to explore the effect different parameter values exert on the sensitivity of other parameters (Alden et al., 2013 ). Yet, we believe that in depth statistical analysis and parameter-fitting through calibration, does not provide enough evidence alone to convince a biologist that a simulation is fit for purpose, nor does it provide access to the model's full informational content.
To ensure that simulations are developed in a principled manner, we advocate use of the CoSMoS (Complex Systems Modeling and Simulation) framework for the development of computational models. We provide a brief description of the process below but direct the reader to Andrews et al. (2010) for a more complete overview. The model should be explicitly stated using a modeling language, such as the Uni-fied Modeling Language (UML), Systems Biology Markup Language (SBML) or the Pi calculus, in terms of biology alone before conversion and abstraction into a platformindependent 'platform model', which may then be implemented through development of an executable software representation of the platform model. Simulation developers should also ensure the implementation is fully transparent: by providing a formal argumentation structure that explains and justifies all assumptions and abstractions with evidence or exposition, such that these can be considered when translating the simulation result into one grounded in the biological domain. Goal-structuring notation has been shown to provide a means of structuring such arguments in the field of safety-critical software systems (Kelly, 1999) . Where simulations are used as a key tool in making biological predictions, clinical trials being one example, it is clear that the tool should be considered safety-critical.
Although these techniques may appeal to the developers of biological simulations, they are not always easily accessible to biologists, nor ideal for validation or predictive purposes. One asset of simulation is its capability of providing high-resolution data which is difficult or impossible to obtain in the wet-lab, while maintaing a level of abstraction that makes the simulation computationally tractable. However, it is for precisely these same reasons that experimental biologists often lack confidence in simulation results, so we argue that model developers need to go further to build confidence in their simulations. Simulation visualizations are commonly too abstract to visually represent a model system as it is conceptualized by biologists. Since simulation outputs do not reflect the format or type of data obtained from wet-laboratory experimental techniques, such as flow cytometry (to measure cell surface expression of specific proteins), histology, or the various approaches to analysing relative gene expression (quantitative polymerase chain reactions, microarrays, deep sequencing, etc), they must be indirectly compared with the biological domain.
In addition to providing transparency in simulation design, a strong argumentation structure, and a comprehensive statistical analysis of the parameter space, we argue modelers must look toward experimental techniques in biology with regard to the simulation outputs chosen. In this paper, we discuss the development of a tool-chain that enables simulations to output data comparable to biological experiments, through the emulation of experimental techniques used with in vitro or in vivo biological model systems. We additionally address the motivations and potential applications driving development of this approach.
The concept of producing a Turing-like test for the validation of biological simulations is discussed at length in Harel (2005) , in which a domain expert is presented with both experimental and simulated datasets, and challenged to identify the experimental data, and whether any discernible difference exists. Much like the Turing test in the field of artificial intelligence, this has been considered the standard to which computational simulations in biology should ultimately aspire to. The principal barrier to developing such a test as a viable validation tool, is negating the significant differences in means of producing, analyzing and presenting data in experimental and computational biology. Therefore, this presents a strong motivation to develop methods for bringing results in computational biology closer to those seen in experimental biology.
Essentially, we argue that to better understand the dynamics of a simulation of biological processes, an in silico emulation of experimental biological techniques is required, and furthermore, that a simulation is more likely to yield useful results when analyzed within the context of the biological techniques that will ultimately be used to test simulation predictions. We found that this process can elucidate new perspectives in a pre-existing model, and identify emergent sub-populations of cells not previously known within the simulation. 
Methodology
A typical approach to experimentation with an existing computational biology simulation is to perform various statistical analyses on simulation outputs for a range of parameter samples. These are then used in an attempt to make predictions about a biological system, which leads to further experimentation with the simulation, and also predictions that could be tested in the web laboratory. However, there does not exist a principled approach to linking the results model of a simulation back to the original biological domain model. We propose the creation of a stronger link between biological models and executable simulations in general by developing simulations that produce outputs that map directly to the types of data produced and used by experimental biologists. It is to this end that we have developed software and protocols for the production of such datatypes that can be applied to pre-existing and new simulations, and enable computational models to be better interpreted within the context of the biology they represent. Figure 1 presents our standard workflow (black rectangles) and incorporates the proposed additional steps (red rectangles) for creating models and simulations that better integrate with experimental biology. The net result of these transformed output is a wider range of outputs that can be used during simulation calibration and validation, and to aid development of directly testable hypotheses in terms of wet laboratory experimentation.
Through the adoption of an agent-based modeling approach, we previously created a computational predictive tool for exploring the mechanisms driving pre-natal lymphoid organ development. This has aided the generation of testable biological hypotheses concerning the complex cellular interactions leading to the generation of organs that trigger adaptive immune responses: interactions which cannot currently be fully explored using laboratory techniques. For the purpose of this paper, we give a brief overview of the model, but direct the reader to our previously published work detailing the simulation design, implementation and analysis Patel et al., 2012; Alden et al., 2013) . The tool captures the 72 hour period of tissue development in pre-natal mice. Populations of hematopoietic cells, known as Lymphoid Tissue Initiator (LTin) and Lymphoid Tissue Inducer (LTi) cells, migrate into the developing gut, with data from laboratory observations suggesting these cells follow a random motion. Both cell populations express receptors for the adhesion molecule VCAM-1, expressed by stromal Lymphoid Tissue Organizer (LTo) cells residing in the gut wall. VCAM-1 causes cells expressing the cognate receptor to adhere to the VCAM-1 expressing cell, thereby restricting its movement. Contact between a hematopoietic cell and LTo cell triggers the LTo cell to differentiate (become more specialized), leading to increased adhesion molecule expression. In addition, LTo cell differentiation increases chemokine secretion, creating a chemokine gradient that promotes migration of the LTi cell population towards the differentiated LTo cell. In the vicinity of LTo cells, movement of LTin and LTi cells will be restricted by adhesion factors (VCAM-1 and others), forming aggregations of hematopoietic cells around LTo cells by the end of the 72 hour period. These aggregations later mature into lymphoid organs called Peyer's patches, which are capable of initiating immune responses against pathogenic bacteria encountered in the gut.
We have previously shown that the emergent cell behavior observed in laboratory experimentation is statistically similar to that observed in the simulation. We utilized sensitivity analysis techniques to explore the simulated biological pathways to reveal those which have a significant impact on simulation response (Patel et al., 2012; Alden et al., 2013) . The output from these statistical techniques provided evidence that our simulation is fit for the purpose of aiding biologists in their exploration of the system. However, we believe that confidence in the simulation would be further increased by providing experimental biologists with simulator outputs that are comparable to primary laboratory data, which can be more intuitively interpreted. Furthermore, such outputs can provide additional insight into the simulation dynamics, enable additional explorative experimentation in silico and furnish mechanistic detail not readily accessible with descriptive nor inferential statistical analyses.
In order to emulate flow cytometry, a simulation requires explicit values for cell surface expression of proteins. Absolute values are not important, rather, it is the relative differences in expression levels that enables the insight afforded by this technique. In the Peyer's patch simulation, expression is strictly binary, such that each cell in the simulation is either expressing a protein or not. An increase in protein expression is achieved by changing the parameters of abstract mathematical functions that determine behavior. For example, LTo chemokine expression levels are abstracted as a sigmoidal cumulative probability density function, sampled at each time step by every LTi cell responsive to chemokine. An increase in chemokine expression level is represented as a reduction in the standard deviation (or tightness) of the sigmoid curve, as detailed in Alden et al. (2012) . Expression of VCAM-1 by LTo cells is handled in a similar manner. Therefore, it is necessary to modify the simulation to provide relative quantitative expression levels without compromising extant simulation dynamics. In these cases, a new agent property needs to be created that represents relative expression of the factor concerned, but is not used by the simulation for decision making purposes. This value is obtained by incrementing (or decreasing) the property each time step in direct proportion to the change in the mathematical function responsible for the protein.
For each time-point a flow cytometric analysis is to be performed, expression levels of each protein of interest are placed into a CSV column and multiplied by a factor of 10 5 prior to bring cast as integers. This ultimately enables flow cytometry software to interpret the values as fluorescent intensities, which are proportional to expression level. Following this, the CSV data is transformed into 'fcs' format compliant files according to the standard described in Spidlen et al. (2010) , which are universally used by modern flow cytometers to store their data output. This is an important step because it allows the data to be interrogated using flow cytometry software, specifically designed for use with biological data.
For this case study, we chose to emulate flow cytometry for the generation of adhesion molecule VCAM-1 expression data. VCAM-1, expressed by LTo cells, is responsible for retaining LTi cells in Peyer's patch formation. We also emulate the forward scatter (FSC) of light that occurs when lasers strike the cell in the flow cytometer, which is proportional to the size of the cell. In the simulation, cells of a given phenotype have the average diameter of those cells as measured experimentally. We adapted the simulation such that the radius is sampled from a truncated gaussian distribution about the mean experimentally measured radius, with a standard deviation of 1µm. This enables identification of cell populations based on both their size and their expression of VCAM-1.
The simulation is written in Java, and utilizes MASON (Luke et al., 2005) , a domain-independent agent-based modeling toolkit. The simulation visualizations in this paper are not MASON dependent, and are also written in Java. Perl and Octave are used to manipulate output CSV data and generate 'fcs' compliant files for use in flow cytometry data analysis software.
Results
This section presents results from the adapted simulation, transformed into biologically homomorphic outputs as an emulation of histology and microscopy, flow cytometry, and relative protein expression. We also explore the application of software designed to automate the analysis of biological images, enabling a high-throughput approach to analysing graphical outputs representing histological staining and microscopy. Figure 2 presents new visualization approaches derived from the existing simulation of Peyer's patch formation. These represent 'unfolded' images of a section of mouse gut, as the simulation is toroidal about the Y axis. All cells in the simulation are stored in a 2-dimensional continuous grid object provided by the MASON agent-based simula- tion toolkit (Luke et al., 2005) . Each object of a particular cell type is extracted from this grid and then drawn to a canvas according to the properties of that cell, as seen in typical immunohistological imaging. In Figure 2A , LTi cells are drawn as green circles ((0,255,0) in the RGB colorspace) on a black canvas, in a manner similar to the appearance of GFP (green fluorescent protein)-stained cells when imaged with confocal microscopy. Overlapping cells produce a region of green with a higher alpha (transparency) value, to enable determination of the density of a region by measuring the level of alpha in that region as compared with the base level assigned to individual cells. LTo cells are illustrated in Figure 2B , drawn red (255,0,0), with an alpha value corresponding to VCAM-1 expression level. LTo cells without sufficient VCAM-1 expression have been colored grey (128, 128, 128) for the purposes of the figure to be rendered visible to the reader. The two canvases undergo several stages of postprocessing before being combined into Figure 2C , as an emulation of immunohistology that shows the co-localization of VCAM-1 expression on LTo cells, and LTi cells. The VCAM-1 canvas undergoes posterisation and a gaussian blur, to provide an interpolated, continuous approximation of VCAM-1 expression in Peyer's patches. Furthermore, a canvas with dark blue circles representing all LTo cells undergoes a gaussian blur and is drawn at 25% transparency, beneath the red VCAM-1 layer. The LTi cell layer is duplicated, with the lower layer undergoing blurring and an increase in transparency to 25% visibility.
An enlarged section of Figure 2C is shown in Figure 3A , illustrating an individual Peyer's patch in silico, alongside an actual confocal microscopy image in Figure 3B of a B Cell follicle in a developing lymph node, included to illustrate how genuine lymphoid tissue histology compares to the in silico emulation. The development process of Peyer's patches and lymph nodes are qualitatively similar, however it is important to note that the cell types and staining in Figure 3B are not the same as those emulated in Figure 3A .
The in silico images are output from the simulation at any pre-specified resolution, with a minimum usable value depending on the diameter of the smallest visualized object. The images may be automatically analyzed en masse to detect the presence of Peyer's patches using CellProfiler pipeline-based image analysis software (Carpenter et al., 2006) for quantitatively identifying and analysing cell phenotypes. This is illustrated in Figure 4 for a single simulation run, but can be applied to an arbitrarily large dataset, using computer clusters if necessary. Prior to the development of this CellProfiler pipeline, identification and quantification of patch formation has proven difficult, as it is achieved in the domain through manual analysis of histology, by eye (Cornes, 1965) . The same CellProfiler pipeline has also successfully been applied to the measurement of developing lymphoid tissue histology obtained using confocal microscopy (data not shown).
The raw fcs formatted data can be analysed in a variety of ways using flow cytometry software. For this case study, we used WEASEL v3.1 (Walter and Eliza Hall Institute of Medical Research). In Figure 5A , a dot-plot of VCAM-1 vs Forward Scatter (FSC) florescent intensity at 72 hours is shown, for every cell in the simulation. This enables identification Figure 5B , the VCAM-1 positive, large cells are isolated and presented as a histogram of VCAM-1 mean florescent intensity. Two peaks in population can be observed, corresponding to the two sub-populations identified in Figure 5A .
The flow cytometry emulation data can be output from the simulation at any desired time-points. This enables flow cytometry to be performed repeatedly at different time-points from the same simulation run, and permits observation of the progression of cell populations over time. To illustrate this, the histogram from Figure 5B is shown at 24-hour intervals over the 72-hour formation process. The time-dependent emergence of the peak population size and VCAM-1 expression level is clearly visible.
Mean protein expression levels can be output from the simulation both over time and across space. This permits the creation of heat maps that capture cell phenotypes spatiotemporally, and can show the progression of protein expression over time and space. Figure 7A shows a sample of 9 cells and their expression of VCAM-1 and chemokine CCL19 at three different time-points. This illustrates the activity through time of particular proteins or genes; in this example, both VCAM-1 and the chemokine CCL19 show significantly more expression during the final 24 hour timepoint. In Figure 7B , the spatially-distributed expression of VCAM-1 is shown at 72 hours for three isolated Peyer's patches that formed during one simulation execution. Figure 6 : VCAM-1 expression histogram for all cells, taken at 24 (long dash), 48 (short dash), and 72 (solid line) hour time-points. The emergence of a prominent peak is visible after 48 hours, and by the end time-point this has diverged into several distinctly identifiable sub-populations, each corresponding to VCAM-1 expression levels within a specific Peyer's patch.
Discussion
The development of simulation outputs that directly reflect data obtained from the laboratory confers several advantages when used to augment current approaches to simulation analysis. Sensitivity analysis and other descriptive statistical methods are extremely important in evaluating simulations, and have proven useful in determining simulation robustness, aleatory uncertainty, and the roles of specific parameters with respect to particular outputs (Marino et al., 2008; Read et al., 2012; Alden et al., 2013) . However, they do not offer the mechanistic insight into the spatial organisation of cells and the structures they form, or the changing cell phenotypes and emergent populations that may be observed using multiple time-point emulated FACS analysis, emulated histology and spatially resolved heat-maps. We therefore argue that current best-practice simulation analysis methodologies should be augmented with emulations of biological experimental techniques. Sensitivity analysis may then be performed that determines the effect magnitude of parameters on more biologically relevant outputs.
The application of the histology emulation module and CellProfiler pipeline to the Peyer's patch simulation has created potential for a new set of experiments that not previously possible. These are to explore how the number of patches, and their morphology, change in response to parameter perturbation and gene-knockouts. Previously, experimentation focused on velocity and displacement of LTi cells as the primary outputs of interest, however we can now measure a large range of properties relating to both the structure of the patches such as compactness, density and area, and also the spatial organization of expressed proteins. Previ- Figure 7 : Heat-maps generated from simulation data over both time and space, to illustrate change in protein expression levels. A. VCAM-1 and CCL19 expression over time for a subset of individual LTo Cells and then the mean level over that subset. B. Spatially-resolved heat-map showing VCAM-1 distribution in three Peyer's Patches that formed during one simulation run.
ously, experiments relating to patch number were intractable due to the large number of replicates per parameter sample required to ameliorate aleatory uncertainty and the lack of a suitable means of identifying and counting patches; clustering algorithms were used in an attempt to count patches based purely on the locations of LTi cells, however they were found to be unreliable. New insight into the model dynamics arose from the simple emulated flow cytometry analysis performed in Figures 5 and 6 . There is a clear emergence of two distinct populations of LTo cells in Figure 5A . Interestingly, we learn from Figure 6 that there is a sudden divergence after 48 hours that created these populations, before which expression levels conformed to a gaussian distribution -an emergent effect in itself. The divergence could be a simulation artifact or it could be that each patch has a relatively uniform distribution of VCAM-1 dependent on its unique properties, such as size and population size of co-localized LTi cells. However, any prediction made from the emulated experimental technique is a prediction arising from the simulation itself, in that the techniques described herein should not effect extant simulation behavior. Such predictions were merely unrecoverable with previously applied analytic techniques. Therefore, validation of the these techniques must be considered within the context of the simulation to which they are applied, as what is a suitable approach for one simulation may be wholly inappropriate when applied to another.
It has been suggested several times throughout development of the field of computational biology, that a reverseTuring test (Sargent, 1991; Harel, 2005) , in which both biological data and simulated data are presented to a biologist, in order to observe whether the simulated dataset can be readily identified, and how. This has largely not been feasible to-date because of the very different manner in which simulation results are presented, and the difficulty in buffering these differences from biological domain experts. Now, with the availability of simulated histology and flow cytometry data, we are quickly approaching the point at which this will become feasible. For instance, prior to the development of the CellProfiler pipeline illustrated in Figure 4 , there was no reliable, automated means by which to identify, count and quantify Peyer's patches over many simulation run results, and simple dots were used for each cell in the simulation visualization layer. Furthermore, there are no other means except emulated flow cytometry to perform an in depth analysis of cell populations and their properties within the simulation. The possibility of simulation and experimental model results becoming indistinguishable is an exciting prospect in terms of accelerating scientific progress in biology and medicine.
Experimental biologists experienced with flow cytometry could identify important patterns, populations and other results that could go unnoticed in other approaches to simulation analysis. Flow cytometry software such as FlowJo (TreeStar) and WEASEL (Walter and Eliza Hall Institute of Medical Research) enable gating of events based on the value of multiple parameters, permitting identification of different phenotypes, and sub-populations within those phenotypes, and an exploration of the properties of these populations. Although for the sake of simplicity and demonstration purposes we chose to emulate flow cytometry with just two factors, depending on the complexity of the simulation, this approach can be extended in silico to an arbitrarily large number of expressed proteins. The multi-dimensional nature of flow cytometry data coupled with software designed specifically for its analysis in a biological context is what makes this approach particularly appealing. Attempting to perform the same sort of analyses on cell populations and phenotypes using the simulation alone, without flow cytometry emulation, would be extremely time consuming and difficult.
The temporally-and spatially-resolved heat-maps presented in Figure 7 have the potential to be combined in various novel ways to demonstrate the development of biological structures through changing gene expression across time and space. In fact, this is an example of a technique grounded in experimental biology, but developed beyond the limits of what is possible experimentally. The same may be said of the flow cytometry analysis performed at multiple time-points: in experimental biology, the act of running a sample through a FACS machine irretrievably destroys it, rendering evaluation of an identical sample at earlier or later time-points impossible in the wet-lab. Therefore, while providing data in a format familiar to biologists, these techniques do not limit simulation results to what is possible within the confines of a wet-lab. We argue that the approaches developed in experimental biology for exploring and visualizing data, did so because of their usefulness in interpreting biological systems, and that these approaches should be broadly extended also to in silico models of biological systems.
Through the application of high performance, highthroughput computing, emulated experimental technique results from many simulations can be analyzed and combined to provide a realistic quantitative analysis of biological simulations to provide data that can be more easily integrated into biological experiments, and enable direct comparison between computational and wet-lab datasets. This approach has the potential to somewhat simplify simulation calibration, given the data output from the simulation takes the same form as biological data, the fitness function of the simulation effectively becomes the primary biological data, allowing systematic exploration of the parameter space to identify the points at which the simulation output is statistically no different from domain experimental data. Combined with genetic algorithms or other evolutionary computation approaches, the speed and accuracy by which simulations may be automatically calibrated by computer could be improved significantly.
In summary, we have presented a methodology and toolchain for generating simulation outputs that are homomorphic to primary biological data. We argue that this improves the validation process, and by allowing direct comparison with the domain, it enhances the confidence one may have in a biological simulation. The tool-chain developed has enabled novel quantification and visualization of computer simulations that was hitherto unachieved, and allows exploration of model dynamics that would have otherwise remained hidden when limited to statistical analyses. We have argued that biological simulations should aim to produce the same data format as that which was used to create it.
Future Work
The groundwork has been laid for a broadly applicable toolkit that may be used to generate histological, FACS and gene expression data from computational simulations. We plan to build upon the histological aspect of the tool-chain by creating a library of drawing and image processing techniques to replicate a wider range of cell phenotypes. The long-term goal is a freely distributable software tool that can be integrated with a wide range of simulations, to produce more biologically relevant outputs that can both inspire confidence that simulations are fit-for-purpose, and improve the simulation analysis process.
